At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
06185 CANSINOBIO
Not Yet Opened 02-23 16:08:03
33.980
+0.520
+1.55%
High34.440Low33.520Vol154.20K
Open33.520D1 Closing33.460Amplitude2.75%
Mkt Cap8.39BTradable Cap4.51BTotal Shares247.04M
T/O5.26MT/O Rate0.12%Tradable Shares132.67M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
CanSino Biologics Inc. (06185) Releases January 2026 Monthly Return on Equity Securities
Bulletin Express  ·  02-04
CanSino Biologics Inc. (06185) Releases January 2026 Monthly Return on Equity Securities
CanSino Biologics Sees Swing to Profit
MT Newswires Live  ·  01-27
CanSino Biologics Sees Swing to Profit
CANSINOBIO (06185) Anticipates 2025 Net Profit Attributable to Owners of RMB 24.5 Million to RMB 29 Million, Turning a Loss into a Profit Year-on-Year
Stock News  ·  01-27
CANSINOBIO (06185) Anticipates 2025 Net Profit Attributable to Owners of RMB 24.5 Million to RMB 29 Million, Turning a Loss into a Profit Year-on-Year
ZhTong A-H Statistics | January 27
Stock News  ·  01-27
ZhTong A-H Statistics | January 27
ZhTong Hong Kong Market Analysis | Strait of Hormuz Sparks Market Jitters, Asset Classes Continue to Draw Interest
Stock News  ·  01-26
ZhTong Hong Kong Market Analysis | Strait of Hormuz Sparks Market Jitters, Asset Classes Continue to Draw Interest
Hong Kong Stocks Movement | Select Pharmaceutical Stocks Rally in Afternoon Session: CANSINOBIO (06185) Surges Over 10%, JUNSHI BIO (01877) Gains Over 5%
Stock News  ·  01-26
Hong Kong Stocks Movement | Select Pharmaceutical Stocks Rally in Afternoon Session: CANSINOBIO (06185) Surges Over 10%, JUNSHI BIO (01877) Gains Over 5%
Financial Insights | Precious Metals Maintain High Heat, Space Infrastructure Concept Erupts
Stock News  ·  01-26
Financial Insights | Precious Metals Maintain High Heat, Space Infrastructure Concept Erupts
Zhitoing A-H Share Statistics | January 19
Stock News  ·  01-19
Zhitoing A-H Share Statistics | January 19
Hong Kong Stock Movement | CANSINOBIO (06185) Rises Nearly 6% Again; 24-Valent Pneumococcal Polysaccharide Conjugate Vaccine Approved for Clinical Trials
Stock News  ·  01-07
Hong Kong Stock Movement | CANSINOBIO (06185) Rises Nearly 6% Again; 24-Valent Pneumococcal Polysaccharide Conjugate Vaccine Approved for Clinical Trials
CanSino Biologics Inc.'s (HKG:6185) last week's 4.5% decline must have disappointed individual investors who have a significant stake
Simply Wall St.  ·  2025-12-30
CanSino Biologics Inc.'s (HKG:6185) last week's 4.5% decline must have disappointed individual investors who have a significant stake
CanSino Biologics Initiates Phase 1 Study of Pediatric Combination Vaccine
MT Newswires Live  ·  2025-12-22
CanSino Biologics Initiates Phase 1 Study of Pediatric Combination Vaccine
CANSINOBIO (06185) Initiates Phase I Clinical Trial for DTcP-Hib-MCV4 Combined Vaccine and Completes First Subject Enrollment
Stock News  ·  2025-12-19
CANSINOBIO (06185) Initiates Phase I Clinical Trial for DTcP-Hib-MCV4 Combined Vaccine and Completes First Subject Enrollment
Southbound Capital Flow Data (T+2) for Dec 8
Stock News  ·  2025-12-08
Southbound Capital Flow Data (T+2) for Dec 8
CanSino Biologics Inc. (06185) Announces November 2025 Monthly Return on Movements in Securities
Bulletin Express  ·  2025-12-03
CanSino Biologics Inc. (06185) Announces November 2025 Monthly Return on Movements in Securities
CanSino (6185) Announces Board and Committee Composition
Bulletin Express  ·  2025-11-27
CanSino (6185) Announces Board and Committee Composition
CanSino Biologics (6185) Announces EGM Results, Amended Articles, and Board Adjustments
Bulletin Express  ·  2025-11-27
CanSino Biologics (6185) Announces EGM Results, Amended Articles, and Board Adjustments
CANSINOBIO (06185): Zuo Min and Ji Xuefeng Elected as Independent Non-Executive Directors
Stock News  ·  2025-11-27
CANSINOBIO (06185): Zuo Min and Ji Xuefeng Elected as Independent Non-Executive Directors
CanSino Biologics Inc. (688185) Announces Cancellation of Treasury Shares, Issued Shares Total 114,372,901
Bulletin Express  ·  2025-11-27
CanSino Biologics Inc. (688185) Announces Cancellation of Treasury Shares, Issued Shares Total 114,372,901
CANSINOBIO (06185) Cancels 406,100 Repurchased Shares
Stock News  ·  2025-11-27
CANSINOBIO (06185) Cancels 406,100 Repurchased Shares
CANSINOBIO (06185) to Cancel 406,100 Repurchased A Shares
Stock News  ·  2025-11-26
CANSINOBIO (06185) to Cancel 406,100 Repurchased A Shares

Introduction

Company Name.
CANSINOBIO
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.
Issue price:
--